本页面由Tiger Trade Technology Pte. Ltd.提供服务

Pieris Pharmaceuticals, Inc.

13.60
0.0000
成交量:- -
成交额:74.30万
市值:1,795.53万
市盈率:-1.09
高:13.60
开:13.60
低:13.60
收:13.60
52周最高:22.32
52周最低:6.20
股本:132.02万
流通股本:77.60万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-12.5338
每股收益(LYR):-21.8005
净资产收益率:-68.21%
总资产收益率:-28.31%
市净率:1.10
市盈率(LYR):-0.62

数据加载中...

2024/08/08

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/08/01

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/07/24

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/07/24

重要事件披露

Form 8-K - Current report
2024/07/03

重要事件披露

Form 8-K - Current report
2024/05/17

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/17

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/29

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/04/18

重要事件披露

Form 8-K - Current report
2024/03/29

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/27

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/21

重要事件披露

Form 8-K - Current report
2023/11/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/01

重要事件披露

Form 8-K/A - Current report: [Amend]